These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21538916)

  • 1. Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for.
    Spasovski G; Ortiz A; Vanholder R; El Nahas M
    Proteomics Clin Appl; 2011 Jun; 5(5-6):233-40. PubMed ID: 21538916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspective.
    Tesch GH
    Nephrology (Carlton); 2010 Sep; 15(6):609-16. PubMed ID: 20883281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary proteomics: a tool to discover biomarkers of kidney diseases.
    Dihazi H; Müller GA
    Expert Rev Proteomics; 2007 Feb; 4(1):39-50. PubMed ID: 17288514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal fibrosis: insight from proteomics in animal models and human disease.
    Klein J; Kavvadas P; Prakoura N; Karagianni F; Schanstra JP; Bascands JL; Charonis A
    Proteomics; 2011 Feb; 11(4):805-15. PubMed ID: 21229585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for chronic kidney disease: which strategy?
    Hallan SI; Stevens P
    J Nephrol; 2010; 23(2):147-55. PubMed ID: 20155721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary proteomics and drug discovery in chronic kidney disease: a new perspective.
    Prunotto M; Ghiggeri GM; Candiano G; Lescuyer P; Hochstrasser D; Moll S
    J Proteome Res; 2011 Jan; 10(1):126-32. PubMed ID: 20718506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of Fabry disease nephropathy.
    Schiffmann R; Waldek S; Benigni A; Auray-Blais C
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):360-4. PubMed ID: 19965549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis in pediatric renal disease.
    Traum AZ; Schachter AD
    Semin Nephrol; 2007 Nov; 27(6):652-7. PubMed ID: 18061847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery.
    Thongboonkerd V
    Expert Rev Proteomics; 2005 Jun; 2(3):349-66. PubMed ID: 16000082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study.
    Johnson ES; Thorp ML; Platt RW; Smith DH
    Am J Kidney Dis; 2008 Oct; 52(4):653-60. PubMed ID: 18585833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications.
    Zürbig P; Dihazi H; Metzger J; Thongboonkerd V; Vlahou A
    Proteomics Clin Appl; 2011 Jun; 5(5-6):256-68. PubMed ID: 21591267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine proteomics biomarkers in renal transplantation: an overview.
    Quintana LF; Bañon-Maneus E; Solé-Gonzalez A; Campistol JM
    Transplantation; 2009 Aug; 88(3 Suppl):S45-9. PubMed ID: 19667961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic potential of urine proteome: a broken mirror of renal diseases.
    Goligorsky MS; Addabbo F; O'Riordan E
    J Am Soc Nephrol; 2007 Aug; 18(8):2233-9. PubMed ID: 17625117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A; Djurdjev O; Beaulieu M; Er L
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proteomics and the kidney: an innovative approach to the study of renal disease].
    Netti GS; Rocchetti MT; Papale M; Centra M; Centonze D; Di Paolo S; Ranieri E; Gesualdo L
    G Ital Nefrol; 2008; 25(2):169-82. PubMed ID: 18350497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.